Second Regular Session | 74th General Assembly
Colorado General AssemblyPresented to the Joint Health Committee on January 9, 2017, as part of the SMART Act Presentation.
Final Report to the Colorado General Assembly by the Legislative Oversight Committee Concerning the Treatment of Persons with Mental Health Disorders in the Criminal and Juvenile Justice Systems.
During the 2017 legislative session, the General Assembly considered numerous measures on child welfare, domestic violence and crimes against children, the juvenile justice system, public school safety, and child care. The bills described in this document passed and became law, unless otherwise...
During the 2017 legislative session, the General Assembly considered measures on environmental matters, public health care issues, and certificates and licenses. The bills and resolutions described below passed and became law, unless otherwise noted.
Final Report to the Colorado General Assembly by the Opioid and Other Substance Use Disorders Interim Study Committee.
During the 2017 legislative session, the General Assembly considered measures related to Colorado’s behavioral health crisis system and the use and misuse of opioids. Other issues considered include child care regulations, child welfare, and a job program for individuals receiving cash...
Presented to the TLRC at its November 2, 2017 meeting.
This issue brief explains Colorado’s Temporary Assistance for Needy Families (TANF) program, known as Colorado Works, which provides financial and other assistance. The federally funded program is overseen at the state level by the Department of Human Services and is administered at the county...
This issue brief addresses the state’s emergency mental health hold procedure, which allows for a person to be involuntarily held for a 72-hour period of treatment and evaluation if he or she appears to have a mental illness and, due to the mental illness, appears to be an imminent danger to...
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.